financetom
Business
financetom
/
Business
/
MCF Energy Provides Germany Drilling Operations Update
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MCF Energy Provides Germany Drilling Operations Update
Sep 15, 2025 6:21 PM

01:12 PM EDT, 09/15/2025 (MT Newswires) -- MCF Energy ( MCFNF ) on Monday said re-drilling continues at its Kinsau-1A well in Germany.

Kinsau-1A is a re-entry and redrill of the historic Kinsau-1 discovery well, originally drilled by Mobil in 1983.

Drillng reached a depth of 3,022 meters on Sept.8. As of Sept.10. The company highlighted a show of hydrocarbons, including some oil on the mud pits and a drilling rate of 7 and 15 meters per hour.

"Germany has significant natural gas resources within their borders which can reduce imports, keep money in Germany and provide energy security for both personal and industrial needs," chief executive James Hill said.

Shares of MCF Energy ( MCFNF ) were last seen up $0.005 to $0.07 on the TSX Venture Exchange.

Price: 0.07, Change: +0.01, Percent Change: +7.69

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Hope Therapeutics and NRx Pharmaceuticals to Acquire Interest in Cohen and Associates for Psychiatry Clinics
BRIEF-Hope Therapeutics and NRx Pharmaceuticals to Acquire Interest in Cohen and Associates for Psychiatry Clinics
Jun 26, 2025
June 26 (Reuters) - NRX Pharmaceuticals Inc ( NRXP ): * HOPE THERAPEUTICS, INC. AND NRX PHARMACEUTICALS, INC. ( NRXP ) ANNOUNCE AGREEMENT TO ACQUIRE INTEREST IN COHEN AND ASSOCIATES, LLC FOR HOPE'S NETWORK OF INTERVENTIONAL PSYCHIATRY CLINICS * NRX PHARMACEUTICALS INC ( NRXP ) - HOPE TO PURCHASE 49% INTEREST IN COHEN AND ASSOCIATES * NRX PHARMACEUTICALS INC (...
Alto Neuroscience Identifies Biomarker in Phase 2 Trial for Major Depressive Disorder Patients
Alto Neuroscience Identifies Biomarker in Phase 2 Trial for Major Depressive Disorder Patients
Jun 26, 2025
08:16 AM EDT, 06/26/2025 (MT Newswires) -- Alto Neuroscience ( ANRO ) said Thursday it was able to identify a patient selection biomarker in its exploratory phase 2 proof-of-concept trial of ALTO-203 in major depressive disorder patients with elevated levels of anhedonia. ALTO-203 demonstrated clear effects on objective measures of attention and wakefulness, in the phase 2 trial, the company...
BRIEF-ESAB to Acquire EWM GmbH, Expanding Equipment Capabilities and Strategic Position
BRIEF-ESAB to Acquire EWM GmbH, Expanding Equipment Capabilities and Strategic Position
Jun 26, 2025
June 26 (Reuters) - ESAB Corp ( ESAB ): * ESAB CORPORATION TO ACQUIRE EWM GMBH, EXPANDING GLOBAL EQUIPMENT CAPABILITIES AND STRENGTHENING STRATEGIC POSITION * ESAB CORP ( ESAB ) - EWM EXPECTED TO GENERATE €120 MILLION REVENUE IN 2025 * ESAB CORP ( ESAB ) - TO BUY EWM FOR ABOUT €275 MILLION Source text: Further company coverage: ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved